Last reviewed · How we verify
Influenza Virus Vaccine Live, Intranasal — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Influenza Virus Vaccine Live, Intranasal (Influenza Virus Vaccine Live, Intranasal) — Tufts Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Influenza Virus Vaccine Live, Intranasal TARGET | Influenza Virus Vaccine Live, Intranasal | Tufts Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Influenza Virus Vaccine Live, Intranasal CI watch — RSS
- Influenza Virus Vaccine Live, Intranasal CI watch — Atom
- Influenza Virus Vaccine Live, Intranasal CI watch — JSON
- Influenza Virus Vaccine Live, Intranasal alone — RSS
Cite this brief
Drug Landscape (2026). Influenza Virus Vaccine Live, Intranasal — Competitive Intelligence Brief. https://druglandscape.com/ci/influenza-virus-vaccine-live-intranasal. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab